What is PCOS, and why does its renaming to PMOS matter? An AIIMS doctor explains

📌 Summary:

• After a global effort led by Monash University, Polycystic Ovary Syndrome (PCOS) will be renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) to better reflect its multisystem nature
• The old name focused only on the ovaries; many women diagnosed with PCOS do not actually have ovarian cysts — what appear as cysts are arrested (immature) follicles
• PMOS captures endocrine, metabolic, reproductive, psychological and dermatological features: obesity, dysglycaemia, Type 2 diabetes, hypertension, dyslipidemia, fatty liver, cardiovascular disease, sleep apnoea; ovulatory dysfunction, infertility, endometrial cancer risk; depression, anxiety, eating disorders; acne and excess facial hair
• The new name will be introduced globally over the next three years; it will not immediately change diagnostic criteria or treatment protocols
• For India, where PCOS prevalence is high, the renaming could encourage earlier screening for blood sugar, cholesterol and blood pressure, and a more multidisciplinary, preventive approach — and help reduce stigma

🎯 UPSC Relevance: GS2 — public health and disease awareness; the importance of accurate medical terminology in diagnosis, communication and reducing stigma; women's health in India.

📝 Prelims Facts:

• PCOS is being renamed PMOS — Polyendocrine Metabolic Ovarian Syndrome
• The global renaming effort was led by Monash University
• The roll-out of the new name will take place over three years

🔑 Key Term: Arrested follicles — immature ovarian follicles that stall mid-development instead of maturing and releasing an egg, appearing as small fluid-filled structures on ultrasound (the source of the 'cyst' misconception).